Vandana Singh
·
August 15, 2025
Benzinga
Precigen's Papzimeos wins FDA approval as the first therapy for adult recurrent respiratory papillomatosis, showing durable results in clinical trials.
read more
September 30, 2025
September 5, 2025
July 30, 2025
Barchart
July 14, 2025
August 14, 2025
Bloomberg